New Zealand - English - Medsafe (Medicines Safety Authority)

novartis new zealand ltd - diclofenac sodium 1 mg/ml;   - eye drops, solution - 300 mcg/0.3ml - active: diclofenac sodium 1 mg/ml   excipient: boric acid polyoxyl 35 castor oil trometamol water for injection - voltaren ophtha eye drops are indicated for: · post-operative inflammation in cataract surgery and other surgical interventions. · prevention of cystoid macular oedema after cataract extraction with lens implantation. · post-traumatic inflammation in non-penetrating wounds. · inhibition of miosis in cataract surgery. · relief of pain and photophobia. · non-infected inflammatory conditions of the anterior segment of the eye.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 1 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; disodium edetate; hydroxypropylbetadex; hydrochloric acid; propylene glycol; trometamol; tyloxapol; water for injections - post-operative inflammation in cataract surgery and other surgical interventions.

United States - English - NLM (National Library of Medicine)

bryant ranch prepack - diclofenac sodium (unii: qtg126297q) (diclofenac - unii:144o8ql0l1) - diclofenac sodium 10 mg in 1 g - voltaren gel is indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands. voltaren gel is contraindicated in the following patients: pregnancy category c prior to 30 weeks gestation; category d starting 30 weeks gestation risk summary use of nsaids, including voltaren gel, during the third trimester of pregnancy increases the risk of premature closure of the fetal ductus arteriosus. avoid use of nsaids, including voltaren gel, in pregnant women starting at 30 weeks of gestation (third trimester). there are no adequate and well-controlled studies of voltaren gel in pregnant women. human and animal studies indicate that diclofenac crosses the placenta. data from observational studies regarding potential embryofetal risks of nsaid use in women in the first or second trimesters of pregnancy are inconclusive. in the general u.s. population, all clinically recognized pregnancies, regardless of drug exposure, have a background rate of 2

Israel - English - Ministry of Health

gsk consumer healthcare, israel ltd - diclofenac sodium - gel - diclofenac sodium 1 % - diclofenac - diclofenac - self medication for the following indications: local treatment of pain, inflammation and swelling due to: • pain and inflammation and swelling in trauma of the tendons, ligaments, muscles and joints, e.g. due to sprains, strains and bruises and/or backache (e.g. sports injuries). • localized forms of soft tissue rheumatism such as tendonitis (e.g.tennis elbow), bursitis.by physicians order :• pain caused by osteoarthrosis of the peripheral joints, as of the knee or fingers

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - diclofenac sodium - solution - 1 mg/ml - diclofenac sodium 1 mg/ml

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - diclofenac sodium - tablet, film coated - 75 mg - diclofenac sodium 75 mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - diclofenac sodium - suppository - 12.5 mg - diclofenac sodium 12.5 mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - diclofenac sodium - suppository - 25 mg - diclofenac sodium 25 mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - diclofenac sodium - suppository - 50 mg - diclofenac sodium 50 mg

Singapore - English - HSA (Health Sciences Authority)

novartis (singapore) pte ltd - diclofenac sodium - enteric coated tablet - 50 mg - diclofenac sodium 50 mg